Captrust Financial Advisors Abb Vie Inc. Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 1,167,761 shares of ABBV stock, worth $227 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

1,167,761

Previous 926,284 26.07%

Holding current value

$227 Million

Previous $169 Million 18.74%

% of portfolio

0.65%

Previous 0.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $37.4 Million - $43.6 Million	241,477 Added 26.07%	1,167,761 $200 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $5.61 Million - $6.39 Million	-35,080 Reduced 3.65%	926,284 $169 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $15.3 Million - $17.2 Million	110,849 Added 13.03%	961,364 $149 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $5.76 Million - $6.67 Million	43,111 Added 5.34%	850,515 $127 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $8.52 Million - $10.6 Million	64,273 Added 8.65%	807,404 $109 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $6.83 Million - $7.86 Million	47,205 Added 6.78%	743,131 $118 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $4.74 Million - $5.69 Million	34,285 Added 5.18%	695,926 $113 Million
Q3 2022 Nov 16, 2022	BUY	$134.21 - $153.93 $13.2 Million - $15.1 Million	98,200 Added 17.43%	661,641 $88.8 Million
Q2 2022 Aug 23, 2022	SELL	$137.62 - $174.96 $4.05 Million - $5.14 Million	-29,396 Reduced 4.96%	563,441 $86.3 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $14.1 Million - $17.9 Million	102,198 Added 20.83%	592,837 $90.8 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $4.3 Million - $5.34 Million	32,588 Added 7.11%	490,639 $79.5 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $5.52 Million - $6.98 Million	51,338 Added 12.62%	458,051 $62 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $7.08 Million - $8.04 Million	66,561 Added 19.57%	406,713 $43.9 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.95 Million - $2.17 Million	18,536 Added 5.76%	340,152 $38.3 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $3.61 Million - $3.98 Million	35,298 Added 12.33%	321,616 $34.8 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.33 Million - $1.8 Million	16,559 Added 6.14%	286,318 $30.7 Million
Q3 2020 Nov 17, 2020	SELL	$85.91 - $100.83 $664,771 - $780,222	-7,738 Reduced 2.79%	269,759 $23.5 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.51 Million - $3.36 Million	34,236 Added 14.07%	277,497 $27.5 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $5.16 Million - $7.83 Million	80,026 Added 49.03%	243,261 $17.9 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $7.42 Million - $9.28 Million	102,827 Added 170.22%	163,235 $14.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $109,144 - $131,222	1,733 Added 2.95%	60,408 $4.57 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $27,265 - $34,851	-415 Reduced 0.7%	58,675 $4.27 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $3.38 Million - $3.98 Million	-43,870 Reduced 42.61%	59,090 $4.76 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $111,559 - $137,582	1,433 Added 1.41%	102,960 $9.49 Million
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $181,998 - $202,325	2,047 Added 2.06%	101,527 $9.6 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $1.74 Million - $2.06 Million	19,371 Added 24.18%	99,480 $9.22 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.18 Million - $1.59 Million	-12,873 Reduced 13.84%	80,109 $7.33 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $8.09 Million - $8.88 Million	90,371 Added 3461.16%	92,982 $8.99 Million
Q3 2017 Feb 16, 2018	BUY	$69.85 - $89.22 $182,378 - $232,953	2,611	2,611 $292,000

Others Institutions Holding ABBV

# of Institutions

3,692

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $343B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Abb Vie Inc. Transaction History